公司资料
Clearside Biomedical 股价、新闻与催化剂
- 股票代码:
- CLSD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for CLSD.
公司概览
业务概览
Clearside Biomedical is a drug-delivery and ophthalmology company focused on delivering therapies directly to the back of the eye. Its platform is built around improving how eye treatments reach retinal tissue.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Clearside sits in specialty ophthalmology biotechnology.
商业模式特征
The company depends on delivery technology, clinical progress, and the ability to create an eye-care franchise.
生物医药行业定位
Clearside is a niche ophthalmology catalyst name whose stock is tied to clinical and delivery milestones.
未来催化剂
- Clearside’s catalysts are suprachoroidal delivery programs and any ophthalmology update that keeps the platform relevant. The market will care about whether the delivery method still differentiates the story.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。